We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.75%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$106B
AUM Growth
+$3.52B
(+3.4%)
Cap. Flow
+$5.21B
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
45.25%
Holding
3,801
New
219
Increased
2,152
Reduced
975
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$647M |
| 2 |
Vanguard Total Bond Market
BND
|
+$580M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$328M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$305M |
| 5 |
Dimensional US Small Cap ETF
DFAS
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$250M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$92.5M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$61.7M |
| 4 |
Apple
AAPL
|
+$27.7M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.35% |
| 2 | Financials | 3.91% |
| 3 | Consumer Discretionary | 1.87% |
| 4 | Healthcare | 1.85% |
| 5 | Communication Services | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Stoke Therapeutics
STOK
$1.82B
| $83.8K | ﹤0.01% |
+12,598
| New | +$117K |
|
3277
Opendoor
OPEN
$3.7B
| $83.6K | ﹤0.01% |
84,742
+8,531
| +11% | +$11.2K |
|
3278
IAMGOLD
IAG
$8.47B
| $83.2K | ﹤0.01% |
13,311
+2,294
| +21% | +$13.6K |
|
3279
Organogenesis Holdings
ORGO
$308M
| $82.9K | ﹤0.01% |
19,187
+1,154
| +6% | +$4.66K |
|
|
BTX
3280
BlackRock Technology and Private Equity Term Trust
BTX
$957M
| $82.2K | ﹤0.01% |
13,132
-694
| -5% | -$5.16K |
|
|
ADAM
3281
Adamas Trust
ADAM
$777M
| $81.5K | ﹤0.01% |
+12,561
| New | +$80K |
|
3282
Braskem
BAK
$980M
| $81.3K | ﹤0.01% |
21,114
-3,870
| -15% | -$16.1K |
|
3283
The RealReal
REAL
$1.34B
| $80.1K | ﹤0.01% |
14,869
+3,664
| +33% | +$27.8K |
|
3284
PUT
DigitalOcean
DOCN
$14.4B
| $80K | ﹤0.01% |
20,000
-10,000
| -33% | -$391K |
|
|
DMF
3285
DELISTED
BNY Mellon Municipal Income
DMF
| $78.4K | ﹤0.01% |
+10,921
| New | +$78.4K |
|
|
RWT
3286
Redwood Trust
RWT
$616M
| $78.3K | ﹤0.01% |
12,892
+2,256
| +21% | +$14.5K |
|
3287
Vir Biotechnology
VIR
$1.47B
| $77.8K | ﹤0.01% |
11,999
-2,189
| -15% | -$19.5K |
|
3288
Amplify Energy
AMPY
$163M
| $77.7K | ﹤0.01% |
+20,788
| New | +$104K |
|
|
NXDR
3289
Nextdoor Holdings
NXDR
$835M
| $77.6K | ﹤0.01% |
50,708
+32,371
| +177% | +$72.3K |
|
3290
Fortrea Holdings
FTRE
$1.85B
| $76.3K | ﹤0.01% |
10,105
+10,096
| +112,178% | +$143K |
|
3291
Vivid Seats
SEAT
$77M
| $75.9K | ﹤0.01% |
1,283
-331
| -21% | -$26.6K |
|
3292
EVgo
EVGO
$200M
| $75.4K | ﹤0.01% |
28,353
+7,679
| +37% | +$23.8K |
|
|
AIOT
3293
PowerFleet Inc
AIOT
$500M
| $75.2K | ﹤0.01% |
13,694
-7,917
| -37% | -$50.8K |
|
3294
Aldeyra Therapeutics
ALDX
$91.7M
| $74.8K | ﹤0.01% |
+13,017
| New | +$76.9K |
|
|
OXLC
3295
Oxford Lane Capital
OXLC
$830M
| $74.6K | ﹤0.01% |
3,161
+203
| +7% | +$5.05K |
|
|
DHC
3296
Diversified Healthcare Trust
DHC
$2.26B
| $74.6K | ﹤0.01% |
31,073
-10,428
| -25% | -$25.7K |
|
3297
FreightCar America
RAIL
$275M
| $73.5K | ﹤0.01% |
13,300
| – | – |
|
3298
IHS Holding
IHS
$2.77B
| $72.4K | ﹤0.01% |
13,869
+1,089
| +9% | +$4.17K |
|
|
VISN
3299
Vistance Networks Inc
VISN
$2.66B
| $70.4K | ﹤0.01% |
13,259
-5,701
| -30% | -$30.3K |
|
3300
Emergent Biosolutions
EBS
$375M
| $70.3K | ﹤0.01% |
14,468
-1,532
| -10% | -$12.7K |
|
Similar funds
Creative Planning's Q1 2025 Portfolio in Review
As of Q1 2025, Creative Planning held 3,801 positions worth $106B, up 3.4% from $103B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $5.21B of net new capital in Q1 2025, opening 219 new positions and adding to 2,152 existing holdings. Its largest new stake was Fidelity Blue Chip Growth ETF: 1,157,513 shares worth $46.3M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $250M trimmed.
- Creative Planning's largest Q1 2025 buy was Fidelity Blue Chip Growth ETF: 1,157,513 shares worth $46.3M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q1 2025, an estimated $647M increase.
- Creative Planning's biggest Q1 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $250M.
- Creative Planning fully exited Blue Owl Capital Corporation III in Q1 2025, selling an estimated $15.5M.
- Creative Planning's ten largest holdings make up 45% of its $106B portfolio in Q1 2025.
- Creative Planning opened 219 new positions and closed 349 in Q1 2025.
- Creative Planning's portfolio value rose 3.4% quarter-over-quarter to $106B.
Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.